These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 10146356)

  • 1. The genetics of coronary artery disease.
    Kwiterovich P
    J Insur Med; 1993; Suppl B():210-5. PubMed ID: 10146356
    [No Abstract]   [Full Text] [Related]  

  • 2. [Lipoprotein(a) as a risk factor for arteriosclerosis].
    Steinmetz A; Utermann G
    Internist (Berl); 1992 Jan; 33(1):24-31. PubMed ID: 1532383
    [No Abstract]   [Full Text] [Related]  

  • 3. Influence of LDL-receptor mutation type on age at first cardiovascular event in patients with familial hypercholesterolaemia.
    Souverein OW; Defesche JC; Zwinderman AH; Kastelein JJ; Tanck MW
    Eur Heart J; 2007 Feb; 28(3):299-304. PubMed ID: 17090611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic research in coronary heart disease.
    Motulsky AG
    Prog Clin Biol Res; 1984; 147():541-8. PubMed ID: 6330756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetics of apolipoprotein B and apolipoprotein AI and premature coronary artery disease.
    Zambon A; Brown BG; Deeb SS; Brunzell JD
    J Intern Med; 2006 May; 259(5):473-80. PubMed ID: 16629853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Genetic aspects of dyslipoproteinemias].
    de Gennes JL
    Bull Acad Natl Med; 1985 Jun; 169(6):729-34. PubMed ID: 3002561
    [No Abstract]   [Full Text] [Related]  

  • 7. Liver transplantation in a subject with familial hypercholesterolemia carrying the homozygous p.W577R LDL-receptor gene mutation.
    Schmidt HH; Tietge UJ; Buettner J; Barg-Hock H; Offner G; Schweitzer S; Dedoussis GV; Rodeck B; Kallfelz HC; Schlitt HJ; Oldhafer K; Klempnauer J
    Clin Transplant; 2008; 22(2):180-4. PubMed ID: 18339137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Evaluation of a newly discovered LDL receptor mutation (exon 10, GAC>AAC, D271N, "FH Graz-1") in familial hypercholesterolemia-- a familystudy].
    de Campo A; Toplak H; Wascher TC; Schallmoser K; Friehs A; Schmidt H; Kostner GM
    Acta Med Austriaca; 1999; 26(1):20-5. PubMed ID: 10230472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The type of LDLR gene mutation predicts cardiovascular risk in children with familial hypercholesterolemia.
    Guardamagna O; Restagno G; Rolfo E; Pederiva C; Martini S; Abello F; Baracco V; Pisciotta L; Pino E; Calandra S; Bertolini S
    J Pediatr; 2009 Aug; 155(2):199-204.e2. PubMed ID: 19446849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetics and molecular biology.
    Rees A
    Curr Opin Lipidol; 1996 Jun; 7(3):U81-4. PubMed ID: 8818519
    [No Abstract]   [Full Text] [Related]  

  • 11. MedPed in Vienna.
    Widhalm K; Schragl-Iro LC
    Atherosclerosis; 1999 Jun; 144(2):469-70. PubMed ID: 10407510
    [No Abstract]   [Full Text] [Related]  

  • 12. Apolipoprotein E polymorphism is not associated with lipid levels and coronary artery disease in Greek patients with familial hypercholesterolaemia.
    Pitsavos C; Choumerianou DM; Skoumas J; Maumus S; Stefanadis C; Dedoussis GV; Visvikis-Siest S
    Clin Exp Med; 2005 Dec; 5(4):196-201. PubMed ID: 16362800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The 3'-UTR C>T polymorphism of the oxidized LDL-receptor 1 (OLR1) gene does not associate with coronary artery disease in Italian CAD patients or with the severity of coronary disease.
    Sentinelli F; Filippi E; Fallarino M; Romeo S; Fanelli M; Buzzetti R; Berni A; Baroni MG
    Nutr Metab Cardiovasc Dis; 2006 Jul; 16(5):345-52. PubMed ID: 16829343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genome-wide association studies of coronary artery disease: have the results of replication studies been replicable?
    Heng CK
    Eur Heart J; 2008 Sep; 29(18):2189-90. PubMed ID: 18667398
    [No Abstract]   [Full Text] [Related]  

  • 15. Familial hypercholesterolemia and coronary heart disease: a HuGE association review.
    Austin MA; Hutter CM; Zimmern RL; Humphries SE
    Am J Epidemiol; 2004 Sep; 160(5):421-9. PubMed ID: 15321838
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term effects of LDL apheresis in patients with severe hypercholesterolemia.
    Sachais BS; Katz J; Ross J; Rader DJ
    J Clin Apher; 2005 Dec; 20(4):252-5. PubMed ID: 15880364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HDL cholesterol levels in patients with molecularly defined familial hypercholesterolemia.
    Miltiadous G; Cariolou MA; Elisaf M
    Ann Clin Lab Sci; 2002; 32(1):50-4. PubMed ID: 11848618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. From the editor: Learning from defects.
    Brown WV
    J Clin Lipidol; 2013; 7(2):91-2. PubMed ID: 23415426
    [No Abstract]   [Full Text] [Related]  

  • 19. CETP (cholesteryl ester transfer protein) promoter -1337 C>T polymorphism protects against coronary atherosclerosis in Japanese patients with heterozygous familial hypercholesterolaemia.
    Takata M; Inazu A; Katsuda S; Miwa K; Kawashiri MA; Nohara A; Higashikata T; Kobayashi J; Mabuchi H; Yamagishi M
    Clin Sci (Lond); 2006 Nov; 111(5):325-31. PubMed ID: 16822236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Familial defective apolipoprotein B versus familial hypercholesterolemia: an assessment of risk.
    Fouchier SW; Defesche JC; Kastelein JJ; Sijbrands EJ
    Semin Vasc Med; 2004 Aug; 4(3):259-64. PubMed ID: 15630635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.